Publicaciones en colaboración con investigadores/as de Cardiff University (4)

2019

  1. Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

    Nature Immunology

  2. ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

    Nature Immunology

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

1997

  1. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

    Hepatology, Vol. 25, Núm. 2, pp. 470-477